Ionis earnings
Web4 apr. 2024 · Ionis Pharmaceuticals, Inc. (IONS) latest earnings report: revenue, EPS, … Web16 jul. 2024 · I am a passionate, dedicated, and growth-oriented researcher with experience in immunology research as well as preclinical drug …
Ionis earnings
Did you know?
Web11 mrt. 2024 · Ionis Pharmaceuticals has a 1 year low of $31.46 and a 1 year high of $48.82. The firm has a market capitalization of $4.97 billion, a price-to-earnings ratio of -18.29 and a beta of 0.57. The company has a debt-to-equity ratio of 2.06, a current ratio of 7.07 and a quick ratio of 7.00. Web5 mei 2024 · Ionis’ shares were up 2.8% on Wednesday in response to the better-than …
Web12 apr. 2024 · Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) issued its earnings results … Web29 jun. 2024 · Jun. 29, 2024, 07:00 AM. BOSTON, June 29, 2024 /PRNewswire/ -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Tracy Palmer ...
Web4 nov. 2024 · During the first nine months of this year, Ionis earned $370 million in revenue and recognized $499 million in non-GAAP operating expenses, reflecting our commitment to advancing our wholly... Web24 feb. 2024 · Ionis' revenue was comprised of the following (amounts in millions): The Company's revenue increased by more than 10 percent compared to 2024 driven in large part by significant partner payments across multiple partnered programs.
Web22 feb. 2024 · In October 2024, Ionis entered into a sale and leaseback transaction for several of its real estate assets. Under the agreement, Ionis received net proceeds of $200 million, with the potential to receive additional payments of up to $40 million plus …
WebIonis annonce des résultats positifs à 66 semaines de l'étude de phase 3 sur l'Eplonter.. 03/23: Ionis Pharmaceuticals annonce que son candidat médicament contre la SLA reçoit un souti.. 03/07: Ionis Pharmaceuticals déclare que la FDA a accepté d'examiner sa demande pour le candid.. 03/07 r documentation inflation packageWeb22 feb. 2024 · Ionis Pharmaceuticals (IONS) came out with a quarterly loss of $0.37 per … r documentation histWeb22 feb. 2024 · Ionis Pharmaceuticals, Inc. (NASDAQ:NASDAQ:IONS) Q4 2024 Results … r documentation case_whenWeb15 feb. 2024 · Ionis Pharmaceuticals (IONS) doesn't possess the right combination of the … r documentation write_xlsxWeb11 apr. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) had its price objective lifted by equities researchers at Morgan Stanley from $40.00 to $42.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 13.79% from … how to source a pictureWebIonis Pharmaceuticals Inc’s revenue jumped 27.16% since last year same period to … r does not find fileWeb11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high of $67.00 and a low of $27.00. Below ... how to source a photo